Healthcare Pharmaceutical Biotech

The Cannabis Industry Built on Schedule III. Federal Courts Are About to Decide Whether That Foundation Holds

August 1, 2026 3:30 PM

The cannabis industry has largely treated the Attorney General's April 2026 Marijuana Rescheduling Order as a settled foundation for future growth. The federal courts have not yet decided whether that foundation is lawful. MMJ International Holdings, Inc. and its subsidiaries are currently involved in multiple separate federal matters examining different aspects of the government's treatment of cannabis: A D.C. Circuit challenge to the...

Read more

Luvo Health Longevity Program Review 2026: Is This the NAD+ and Sermorelin Vitality Plan Aging-Well Buyers Have Been Searching For?

August 1, 2026 3:20 PM

Quick disclosure before you dive in: this is a paid advertorial, and a commission may be earned if you enroll through a link here. Everything below is attributed to Luvo Health and isn't independently verified by this publication. One quick basic: this is a telehealth service built around compounded medications. Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate - approval isn't guaranteed. This...

Read more

Better U Reviews & Complaints 2026: Is the At-Home Ketamine Program Legit? FDA Warning, Pricing, and Refund Terms Explained

August 1, 2026 2:00 PM

Quick disclosure before you dive in: this is a paid advertorial, and a commission is earned if you purchase through links in this article. Product claims belong to the brand and aren't independently endorsed here. Better U markets an at-home, prescription ketamine program for depression, anxiety, and PTSD - ketamine itself is FDA-approved only as an anesthetic, so using it for psychiatric conditions is off-label. Better U, Inc. is a non-clinical...

Read more

Australian Healthcare Buyers Issue a Warning to Technology Vendors: Innovation Alone Will Not Win 2027 Contracts

August 1, 2026 10:45 AM

Australian healthcare technology buyers are raising the standard for digital transformation investments, demanding that vendors prove safety, integration and execution capability before advancing beyond demonstrations and pilots. A new Black Book Research buyer-priority pulse survey conducted among 177 Australian healthcare decision-makers identifies three issues that will determine which technology suppliers gain momentum in the next wave of...

Read more

CardioFlush Reviews & Complaints 2026: Is This the Daily Heart-Support Formula Buyers Have Been Searching For?

August 1, 2026 10:25 AM

The video uses his name and likeness. Here's what independent reviewers found - plus CardioFlush's pricing and guarantee terms, checked against the brand's own pages. Quick disclosure: this is a paid advertorial, and a commission is earned if you purchase through links below. Product claims belong to the brand, not this publication. CardioFlush is a dietary supplement - not FDA-approved, not a drug, and not intended to diagnose, treat, cure, or...

Read more

Everyday Dose Mushroom Coffee+ Reviews and Complaints 2026: Is This the Morning Upgrade Coffee Drinkers Want?

July 31, 2026 9:55 PM

Quick disclosure before you read further: This is a paid advertorial. A commission is earned, at no additional cost to you, if you purchase through links in this article. Product claims are attributed to the brand and are not independently endorsed. Everyday Dose Mushroom Coffee+ is a dietary supplement - not a drug, not FDA-approved, and per the brand's own disclaimer, not intended to diagnose, treat, cure, or prevent any disease, including...

Read more

Maximus GLP-1 Reviews & Complaints 2026: Could This Be the Clinician-Guided Weight-Loss Upgrade Buyers Have Been Searching For?

July 31, 2026 8:55 PM

Quick note on the title: "Reviews & Complaints" means brand-published testimonials, real BBB complaints, and this article's own review - not a star rating this publication assigns. "The FDA Warning Letter" refers to an actual FDA letter and specific, still-live language on Maximus's own homepage, both detailed below with a direct link to FDA.gov. This publication doesn't independently vouch for any brand claim below - the specifics are coming...

Read more

Luvo Health Reviews and Complaints 2026: Is This the Clinician-Guided Longevity Upgrade Wellness-Focused Buyers Have Been Looking For?

July 31, 2026 8:30 PM

This is promotional content intended for consumer education about a commercially available service. This is a paid advertorial. A commission may be earned when purchases are made through links in this article. Program claims are attributed to Luvo Health and are not independently endorsed. A note on the medications discussed below: Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Details...

Read more

BioNxt Solutions Announces Option Grants

July 31, 2026 6:25 PM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:4XT) announces that it has granted an aggregate of 750,000 stock options ("Options") pursuant to the Company's stock option plan (the "Option Plan") to certain insiders, consultants and an employee of the Company, each Option entitling the holder thereof to acquire one common share of the Company (a "Common Share") at an exercise price of $0.33 for a period of three...

Read more

Medical Care Technologies Demonstrates Broad Monetization Power Across AI Vision, Software Development and Digital Platforms (OTC Pink:MDCE)

July 31, 2026 9:17 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today highlighted the expanding commercial reach of its technology portfolio, underscoring the Company's ability to generate revenue across multiple software and AI vision verticals while continuing development of its medical-grade imaging applications. MDCE's diversified approach spans mobile applications, custom web development, AI vision software, and backend logistics solutions for corporate...

Read more

DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM)

July 31, 2026 8:30 AM

DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI" or the "Company"), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the compliant monetization of health data by market participants, today announced that its wholly-owned online pharmacy, Corexa Pharmacy (www.CorexaRx.com/store), has begun direct-to-consumer (DTC)...

Read more

Handa Oncology Receives FDA Tentative Approval for OMCAZIO (cabozantinib) Capsules

July 31, 2026 8:00 AM

Handa Pharmaceuticals, Inc. ("Handa") (TSE:6620) announced that the U.S. Food and Drug Administration ("FDA") has granted tentative approval to OMCAZIOTM (cabozantinib) capsules, a novel alternate-salt formulation of cabozantinib developed by Handa's U.S. subsidiary, Handa Oncology, LLC (the "Company"). OMCAZIO (cabozantinib) capsules are indicated for the treatment of: adult patients with advanced renal cell carcinoma (RCC); adult patients with...

Read more

Malaysia Emerges as Asia's Fastest-Moving EHR Growth Markets, Black Book Research Reports

July 31, 2026 7:00 AM

Black Book Market Research today released the Malaysia Digital Health Competitive Intelligence Report: Outlook 2027-2029, a 33-page assessment of Malaysia's expanding electronic health record, hospital information system, primary-care digitization, interoperability and national health-data infrastructure market. The report identifies Malaysia as one of Asia's most active emerging EHR growth markets as the country moves from individual hospital...

Read more

Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates

July 31, 2026 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today reported financial results and provided business updates for the second quarter of 2026. "The second quarter marked another period of strong execution for Moderna as we advanced our pipeline and strengthened our financial profile with an improved 2026 operating expense outlook," said Stéphane Bancel, Chief Executive Officer of Moderna. "In the second half of 2026, we are preparing for the potential approval of...

Read more

Cantargia Announces Changes in Number of Shares and Votes

July 31, 2026 4:20 AM

Cantargia AB (publ) ("Cantargia") (Nasdaq Stockholm:CANTA) today announced that the number of shares and votes in Cantargia has changed due to the recently completed rights issue (for further information, see the company's press release from June 23, 2026). Through the rights issue, the number of shares and votes increased by 33,333,333. Today, on the last trading day of the month, the number of shares and votes in Cantargia amounts to...

Read more

New Number of Shares and Votes in IRLAB Therapeutics AB

July 31, 2026 1:20 AM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - During July 2026, the registered number of shares and votes in IRLAB Therapeutics AB ("IRLAB" or the "Company") has changed as a result of the Company's recently completed rights issue and overallotment issue of ordinary shares of series A, which the Board of Directors resolved on 5 May 2026 and which were approved by the Extraordinary General Meeting on 5 June 2026. As of 31 July 2026, the total...

Read more

DirectMax Reviews 2026: Could This Be the Discreet 3-in-1 Telehealth Option Men Have Been Waiting For?

July 30, 2026 10:00 PM

Advertorial disclosure: This article contains affiliate links, and a commission may be earned at no additional cost to the reader. DirectMax requires evaluation and approval by a licensed healthcare provider. Approval and individual outcomes are not guaranteed. DirectMax is compounded, and compounded medications are not FDA-approved. This article is informational and does not replace professional medical advice. Review the current DirectMax...

Read more

Michel Alkhalil, M.D., Announces Integrated Specialty Care Offerings at AAIRS Clinic and Troy Sleep Center

July 30, 2026 5:42 PM

Michel Alkhalil, M.D., medical director of multi-specialty practice AAIRS Clinic and Troy Sleep Center, today announced the practice's physician-led approach, delivering integrated sleep, allergy, immunology, and pulmonology care to patients across Oakland and Macomb counties. Michel Alkhalil, M.D., Medical Director for AAIRS Clinic and Troy Sleep Center. / Source: Michel Alkhalil, M.D. (EZ Newswire) AAIRS Clinic and Troy Sleep Center bring...

Read more

Ireland Emerges as One of the World's Most Active EHR Growth Markets, Black Book Research Reports

July 30, 2026 5:00 PM

Black Book Market Research today announced findings from its new Ireland Digital Health Competitive Intelligence Report: Outlook 2026-2027, identifying Ireland as one of the world's most active near-term electronic health record and digital health growth markets. Based on a survey of 200 Irish healthcare IT, clinical, procurement, privacy, cybersecurity and digital transformation decision makers, the report finds that Ireland is moving beyond...

Read more

Medi-Share Receives Annual Health Care Sharing Accreditation

July 30, 2026 3:30 PM

Medi-Share, the nation's leading health care sharing ministry and the first ministry to be awarded accreditation from the Health Care Sharing Accreditation Board (HCSAB), has received annual accreditation once again, having done so consistently every year since the HCSAB launched in 2022. This accreditation provides independent, third-party validation of Medi-Share's financial integrity and commitment to operational excellence, confirming that...

Read more